Welcome to our dedicated page for AMERISOURCEBERGEN news (Ticker: abc), a resource for investors and traders seeking the latest updates and insights on AMERISOURCEBERGEN stock.
Cencora, Inc. (NYSE: COR) is a global pharmaceutical solutions leader driving innovation across healthcare supply chains. This page provides investors and industry professionals with essential updates on Cencora's strategic initiatives, financial developments, and operational milestones.
Access real-time press releases and analysis covering Cencora's pharmaceutical services, including distribution network expansions, biopharma partnerships, and regulatory advancements. Track key developments such as acquisitions in specialty healthcare, global commercialization efforts, and social responsibility programs through the Cencora Impact Foundation.
Stay informed about critical updates including earnings reports, supply chain innovations, and strategic investments like the OneOncology and PharmaLex acquisitions. Our curated news collection ensures you never miss developments impacting Cencora's position as a Fortune 500 healthcare leader operating in 50+ countries.
Bookmark this page for streamlined access to verified updates about Cencora's pharmaceutical distribution services, venture capital activities through Cencora Ventures, and initiatives advancing global healthcare access. Check regularly for authoritative insights into this NYSE-listed industry pioneer.
AmerisourceBergen Corporation (NYSE: ABC) has declared a quarterly dividend of $0.44 per common share, set to be paid on March 1, 2021. This dividend will be distributed to stockholders recorded as of the close of business on February 12, 2021. As a leading provider in the pharmaceutical supply chain, AmerisourceBergen generated over $185 billion in annual revenue and ranks #10 on the Fortune 500 list, demonstrating its significant market presence.
AmerisourceBergen Corporation (NYSE: ABC) has updated its fiscal year 2021 guidance, projecting adjusted diluted earnings per share (EPS) between $8.25 and $8.50, an increase from the previous range of $8.20 to $8.45. This revision reflects strong operating income performance and does not account for any contributions from the anticipated Alliance Healthcare acquisition or the newly announced U.S. partnership. The company will further discuss this updated outlook in upcoming investor discussions.
AmerisourceBergen (ABC) will acquire Walgreens Boots Alliance's (WBA) Alliance Healthcare for $6.5 billion, comprising $6.275 billion in cash and 2 million shares. This acquisition enhances AmerisourceBergen's global distribution capabilities and allows WBA to focus on its retail pharmacy expansion. The deal is projected to create annual run-rate synergies of at least $150 million by the fourth year. Additionally, the U.S. distribution agreement is extended to 2029, aiming for greater efficiencies. AmerisourceBergen expects a high-teens percentage accretion to adjusted EPS in the first fiscal year after closing.
AmerisourceBergen (NYSE: ABC) is set to disclose its First Quarter 2021 results on February 4, 2021, before NYSE trading opens. A conference call will follow at 8:30 a.m. ET, featuring Steven H. Collis, CEO, and James F. Cleary, CFO. Interested parties can join the call at (844) 808-6694 or via a webcast on the company’s website. Additionally, AmerisourceBergen will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on January 5, 2021, and the J.P. Morgan Healthcare Conference on January 11, 2021.
AmerisourceBergen Corporation (ABC) reported a 7.9% revenue increase to $49.2 billion for Q4 fiscal 2020, with full fiscal year revenue up 5.7% to $189.9 billion. Despite a GAAP diluted EPS loss of $(23.74) due to a $6.6 billion opioid litigation expense, adjusted diluted EPS rose 17.4% to $1.89. The company emphasized its resilience and growth potential for fiscal 2021, focusing on its pharmaceutical-centric services. A quarterly dividend of $0.44, up 5%, was also declared, payable on November 30, 2020.
AmerisourceBergen Corporation (NYSE: ABC) will release its Fourth Quarter Fiscal 2020 results on November 5, 2020, before the NYSE opens. A conference call is scheduled at 8:00 a.m. ET the same day, featuring CEO Steven H. Collis and CFO James F. Cleary. Investors can join the call by dialing (844) 808-6694 or from outside the U.S. at +1 (412) 317-5282. The event will also be webcast on the company's investor relations website. Replays will be available shortly after the call concludes.
